nodes	percent_of_prediction	percent_of_DWPC	metapath
Lomitapide—P-Glycoprotein Inhibitors—Zonisamide—epilepsy syndrome	0.516	1	CiPCiCtD
Lomitapide—ABCB1—epilepsy syndrome	0.0988	1	CbGaD
Lomitapide—ABCB1—Levetiracetam—epilepsy syndrome	0.0226	0.0906	CbGbCtD
Lomitapide—ABCB1—Clobazam—epilepsy syndrome	0.0156	0.0628	CbGbCtD
Lomitapide—ABCB1—Lamotrigine—epilepsy syndrome	0.015	0.0605	CbGbCtD
Lomitapide—ABCB1—Carbamazepine—epilepsy syndrome	0.013	0.0521	CbGbCtD
Lomitapide—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0124	0.0497	CbGbCtD
Lomitapide—ABCB1—Phenytoin—epilepsy syndrome	0.0116	0.0467	CbGbCtD
Lomitapide—CYP3A4—Trimethadione—epilepsy syndrome	0.0115	0.0462	CbGbCtD
Lomitapide—CYP3A4—Felbamate—epilepsy syndrome	0.0115	0.0462	CbGbCtD
Lomitapide—CYP3A4—Fosphenytoin—epilepsy syndrome	0.0108	0.0434	CbGbCtD
Lomitapide—ABCB1—Phenobarbital—epilepsy syndrome	0.0104	0.0416	CbGbCtD
Lomitapide—ABCB1—Midazolam—epilepsy syndrome	0.0102	0.041	CbGbCtD
Lomitapide—ABCB1—Diazepam—epilepsy syndrome	0.00982	0.0395	CbGbCtD
Lomitapide—CYP3A4—Clonazepam—epilepsy syndrome	0.00977	0.0393	CbGbCtD
Lomitapide—CYP3A4—Clobazam—epilepsy syndrome	0.00937	0.0376	CbGbCtD
Lomitapide—CYP3A4—Rufinamide—epilepsy syndrome	0.00796	0.032	CbGbCtD
Lomitapide—CYP3A4—Carbamazepine—epilepsy syndrome	0.00776	0.0312	CbGbCtD
Lomitapide—CYP3A4—Primidone—epilepsy syndrome	0.00724	0.0291	CbGbCtD
Lomitapide—CYP3A4—Phenytoin—epilepsy syndrome	0.00696	0.028	CbGbCtD
Lomitapide—CYP3A4—Propofol—epilepsy syndrome	0.00649	0.0261	CbGbCtD
Lomitapide—CYP3A4—Acetazolamide—epilepsy syndrome	0.0062	0.0249	CbGbCtD
Lomitapide—CYP3A4—Phenobarbital—epilepsy syndrome	0.0062	0.0249	CbGbCtD
Lomitapide—CYP3A4—Midazolam—epilepsy syndrome	0.00612	0.0246	CbGbCtD
Lomitapide—CYP3A4—Diazepam—epilepsy syndrome	0.00588	0.0236	CbGbCtD
Lomitapide—CYP3A4—Zonisamide—epilepsy syndrome	0.00574	0.0231	CbGbCtD
Lomitapide—CYP3A4—Valproic Acid—epilepsy syndrome	0.00464	0.0186	CbGbCtD
Lomitapide—CYP3A4—Topiramate—epilepsy syndrome	0.00418	0.0168	CbGbCtD
Lomitapide—Fexofenadine—SLCO1A2—epilepsy syndrome	0.00064	0.512	CrCbGaD
Lomitapide—Antrafenine—PTGS2—epilepsy syndrome	0.000339	0.271	CrCbGaD
Lomitapide—Fexofenadine—CYP2D6—epilepsy syndrome	0.000158	0.126	CrCbGaD
Lomitapide—Fexofenadine—ABCB1—epilepsy syndrome	0.000113	0.0901	CrCbGaD
Lomitapide—MTTP—Metabolism—ALDH7A1—epilepsy syndrome	7.67e-05	0.00313	CbGpPWpGaD
Lomitapide—MTTP—Circadian rythm related genes—JUN—epilepsy syndrome	7.53e-05	0.00307	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—ST3GAL3—epilepsy syndrome	7.51e-05	0.00306	CbGpPWpGaD
Lomitapide—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—epilepsy syndrome	7.42e-05	0.00303	CbGpPWpGaD
Lomitapide—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—epilepsy syndrome	7.41e-05	0.00302	CbGpPWpGaD
Lomitapide—CYP3A4—Tryptophan metabolism—UBE3A—epilepsy syndrome	7.38e-05	0.00301	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—ADSL—epilepsy syndrome	7.35e-05	0.003	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—GLUL—epilepsy syndrome	7.21e-05	0.00294	CbGpPWpGaD
Lomitapide—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—EPO—epilepsy syndrome	7.1e-05	0.00289	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—CACNA1D—epilepsy syndrome	7.08e-05	0.00289	CbGpPWpGaD
Lomitapide—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C19—epilepsy syndrome	6.99e-05	0.00285	CbGpPWpGaD
Lomitapide—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—epilepsy syndrome	6.91e-05	0.00282	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—TXNRD1—epilepsy syndrome	6.62e-05	0.0027	CbGpPWpGaD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—ABCG2—epilepsy syndrome	6.52e-05	0.00266	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—AQP1—epilepsy syndrome	6.43e-05	0.00262	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	6.17e-05	0.00252	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—CHRM3—epilepsy syndrome	5.81e-05	0.00237	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—KCNJ11—epilepsy syndrome	5.81e-05	0.00237	CbGpPWpGaD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—EPO—epilepsy syndrome	5.6e-05	0.00228	CbGpPWpGaD
Lomitapide—CYP3A4—Metapathway biotransformation—KCNAB2—epilepsy syndrome	5.44e-05	0.00222	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	5.41e-05	0.00221	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—NTF3—epilepsy syndrome	5.31e-05	0.00216	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	5.3e-05	0.00216	CbGpPWpGaD
Lomitapide—Constipation—Carbamazepine—epilepsy syndrome	5.22e-05	0.000472	CcSEcCtD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—CXCL12—epilepsy syndrome	5.22e-05	0.00213	CbGpPWpGaD
Lomitapide—Dizziness—Propofol—epilepsy syndrome	5.21e-05	0.000471	CcSEcCtD
Lomitapide—Diarrhoea—Levetiracetam—epilepsy syndrome	5.21e-05	0.000471	CcSEcCtD
Lomitapide—Weight decreased—Topiramate—epilepsy syndrome	5.2e-05	0.000471	CcSEcCtD
Lomitapide—Gastrointestinal pain—Oxcarbazepine—epilepsy syndrome	5.2e-05	0.000471	CcSEcCtD
Lomitapide—Dyspepsia—Lamotrigine—epilepsy syndrome	5.19e-05	0.00047	CcSEcCtD
Lomitapide—Malnutrition—Pregabalin—epilepsy syndrome	5.19e-05	0.00047	CcSEcCtD
Lomitapide—Malaise—Valproic Acid—epilepsy syndrome	5.18e-05	0.000469	CcSEcCtD
Lomitapide—Vertigo—Valproic Acid—epilepsy syndrome	5.16e-05	0.000467	CcSEcCtD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—SLC2A1—epilepsy syndrome	5.16e-05	0.0021	CbGpPWpGaD
Lomitapide—Asthenia—Vigabatrin—epilepsy syndrome	5.14e-05	0.000465	CcSEcCtD
Lomitapide—Decreased appetite—Lamotrigine—epilepsy syndrome	5.13e-05	0.000464	CcSEcCtD
Lomitapide—Infestation—Topiramate—epilepsy syndrome	5.13e-05	0.000464	CcSEcCtD
Lomitapide—Infestation NOS—Topiramate—epilepsy syndrome	5.13e-05	0.000464	CcSEcCtD
Lomitapide—Flatulence—Pregabalin—epilepsy syndrome	5.12e-05	0.000463	CcSEcCtD
Lomitapide—Eye disorder—Gabapentin—epilepsy syndrome	5.11e-05	0.000463	CcSEcCtD
Lomitapide—Dizziness—Midazolam—epilepsy syndrome	5.1e-05	0.000461	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Lamotrigine—epilepsy syndrome	5.09e-05	0.000461	CcSEcCtD
Lomitapide—Body temperature increased—Clonazepam—epilepsy syndrome	5.09e-05	0.000461	CcSEcCtD
Lomitapide—Abdominal pain—Clonazepam—epilepsy syndrome	5.09e-05	0.000461	CcSEcCtD
Lomitapide—Fatigue—Lamotrigine—epilepsy syndrome	5.09e-05	0.00046	CcSEcCtD
Lomitapide—Cardiac disorder—Gabapentin—epilepsy syndrome	5.08e-05	0.000459	CcSEcCtD
Lomitapide—Palpitations—Valproic Acid—epilepsy syndrome	5.08e-05	0.000459	CcSEcCtD
Lomitapide—Asthenia—Diazepam—epilepsy syndrome	5.06e-05	0.000458	CcSEcCtD
Lomitapide—Body temperature increased—Phenytoin—epilepsy syndrome	5.06e-05	0.000457	CcSEcCtD
Lomitapide—Constipation—Lamotrigine—epilepsy syndrome	5.05e-05	0.000456	CcSEcCtD
Lomitapide—Nausea—Acetazolamide—epilepsy syndrome	5.04e-05	0.000456	CcSEcCtD
Lomitapide—Dizziness—Levetiracetam—epilepsy syndrome	5.04e-05	0.000456	CcSEcCtD
Lomitapide—Feeling abnormal—Carbamazepine—epilepsy syndrome	5.03e-05	0.000455	CcSEcCtD
Lomitapide—Abdominal pain—Oxcarbazepine—epilepsy syndrome	5.03e-05	0.000455	CcSEcCtD
Lomitapide—Body temperature increased—Oxcarbazepine—epilepsy syndrome	5.03e-05	0.000455	CcSEcCtD
Lomitapide—Diarrhoea—Fosphenytoin—epilepsy syndrome	5.03e-05	0.000455	CcSEcCtD
Lomitapide—Back pain—Pregabalin—epilepsy syndrome	5.02e-05	0.000455	CcSEcCtD
Lomitapide—Vomiting—Propofol—epilepsy syndrome	5.01e-05	0.000453	CcSEcCtD
Lomitapide—Muscle spasms—Pregabalin—epilepsy syndrome	4.99e-05	0.000452	CcSEcCtD
Lomitapide—Gastrointestinal pain—Carbamazepine—epilepsy syndrome	4.99e-05	0.000452	CcSEcCtD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—CAPN1—epilepsy syndrome	4.99e-05	0.00203	CbGpPWpGaD
Lomitapide—Headache—Propofol—epilepsy syndrome	4.94e-05	0.000447	CcSEcCtD
Lomitapide—Mediastinal disorder—Gabapentin—epilepsy syndrome	4.93e-05	0.000446	CcSEcCtD
Lomitapide—Chills—Gabapentin—epilepsy syndrome	4.91e-05	0.000444	CcSEcCtD
Lomitapide—Vomiting—Midazolam—epilepsy syndrome	4.9e-05	0.000444	CcSEcCtD
Lomitapide—Diarrhoea—Vigabatrin—epilepsy syndrome	4.9e-05	0.000443	CcSEcCtD
Lomitapide—Asthenia—Felbamate—epilepsy syndrome	4.9e-05	0.000443	CcSEcCtD
Lomitapide—Chest pain—Valproic Acid—epilepsy syndrome	4.89e-05	0.000443	CcSEcCtD
Lomitapide—Arthralgia—Valproic Acid—epilepsy syndrome	4.89e-05	0.000443	CcSEcCtD
Lomitapide—Myalgia—Valproic Acid—epilepsy syndrome	4.89e-05	0.000443	CcSEcCtD
Lomitapide—Haematuria—Topiramate—epilepsy syndrome	4.89e-05	0.000442	CcSEcCtD
Lomitapide—Feeling abnormal—Lamotrigine—epilepsy syndrome	4.86e-05	0.00044	CcSEcCtD
Lomitapide—Dizziness—Fosphenytoin—epilepsy syndrome	4.86e-05	0.00044	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—epilepsy syndrome	4.86e-05	0.000439	CcSEcCtD
Lomitapide—Vomiting—Levetiracetam—epilepsy syndrome	4.84e-05	0.000438	CcSEcCtD
Lomitapide—Discomfort—Valproic Acid—epilepsy syndrome	4.83e-05	0.000437	CcSEcCtD
Lomitapide—Headache—Midazolam—epilepsy syndrome	4.83e-05	0.000437	CcSEcCtD
Lomitapide—Abdominal pain—Carbamazepine—epilepsy syndrome	4.83e-05	0.000437	CcSEcCtD
Lomitapide—Body temperature increased—Carbamazepine—epilepsy syndrome	4.83e-05	0.000437	CcSEcCtD
Lomitapide—Diarrhoea—Diazepam—epilepsy syndrome	4.83e-05	0.000437	CcSEcCtD
Lomitapide—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	4.83e-05	0.000437	CcSEcCtD
Lomitapide—Ill-defined disorder—Pregabalin—epilepsy syndrome	4.82e-05	0.000436	CcSEcCtD
Lomitapide—Sinusitis—Topiramate—epilepsy syndrome	4.81e-05	0.000435	CcSEcCtD
Lomitapide—Anaemia—Pregabalin—epilepsy syndrome	4.8e-05	0.000434	CcSEcCtD
Lomitapide—Asthenia—Zonisamide—epilepsy syndrome	4.79e-05	0.000434	CcSEcCtD
Lomitapide—Dry mouth—Valproic Acid—epilepsy syndrome	4.78e-05	0.000433	CcSEcCtD
Lomitapide—Headache—Levetiracetam—epilepsy syndrome	4.77e-05	0.000432	CcSEcCtD
Lomitapide—Malnutrition—Gabapentin—epilepsy syndrome	4.76e-05	0.000431	CcSEcCtD
Lomitapide—MTTP—Metabolism—ABCG2—epilepsy syndrome	4.74e-05	0.00193	CbGpPWpGaD
Lomitapide—Dizziness—Vigabatrin—epilepsy syndrome	4.74e-05	0.000429	CcSEcCtD
Lomitapide—Flatulence—Gabapentin—epilepsy syndrome	4.69e-05	0.000425	CcSEcCtD
Lomitapide—Malaise—Pregabalin—epilepsy syndrome	4.68e-05	0.000424	CcSEcCtD
Lomitapide—Nausea—Propofol—epilepsy syndrome	4.68e-05	0.000424	CcSEcCtD
Lomitapide—Vomiting—Fosphenytoin—epilepsy syndrome	4.67e-05	0.000423	CcSEcCtD
Lomitapide—Diarrhoea—Felbamate—epilepsy syndrome	4.67e-05	0.000423	CcSEcCtD
Lomitapide—Vertigo—Pregabalin—epilepsy syndrome	4.67e-05	0.000422	CcSEcCtD
Lomitapide—Body temperature increased—Lamotrigine—epilepsy syndrome	4.67e-05	0.000422	CcSEcCtD
Lomitapide—Abdominal pain—Lamotrigine—epilepsy syndrome	4.67e-05	0.000422	CcSEcCtD
Lomitapide—Dizziness—Diazepam—epilepsy syndrome	4.66e-05	0.000422	CcSEcCtD
Lomitapide—Infection—Valproic Acid—epilepsy syndrome	4.66e-05	0.000421	CcSEcCtD
Lomitapide—Asthenia—Clonazepam—epilepsy syndrome	4.62e-05	0.000418	CcSEcCtD
Lomitapide—MTTP—Metabolism—CYP2C19—epilepsy syndrome	4.62e-05	0.00188	CbGpPWpGaD
Lomitapide—Back pain—Gabapentin—epilepsy syndrome	4.61e-05	0.000417	CcSEcCtD
Lomitapide—Headache—Fosphenytoin—epilepsy syndrome	4.6e-05	0.000417	CcSEcCtD
Lomitapide—Nervous system disorder—Valproic Acid—epilepsy syndrome	4.6e-05	0.000416	CcSEcCtD
Lomitapide—Palpitations—Pregabalin—epilepsy syndrome	4.59e-05	0.000415	CcSEcCtD
Lomitapide—MTTP—Metabolism—CYP11A1—epilepsy syndrome	4.59e-05	0.00187	CbGpPWpGaD
Lomitapide—Asthenia—Phenytoin—epilepsy syndrome	4.59e-05	0.000415	CcSEcCtD
Lomitapide—Nausea—Midazolam—epilepsy syndrome	4.58e-05	0.000414	CcSEcCtD
Lomitapide—Muscle spasms—Gabapentin—epilepsy syndrome	4.58e-05	0.000414	CcSEcCtD
Lomitapide—Diarrhoea—Zonisamide—epilepsy syndrome	4.57e-05	0.000414	CcSEcCtD
Lomitapide—Asthenia—Oxcarbazepine—epilepsy syndrome	4.57e-05	0.000413	CcSEcCtD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	4.56e-05	0.00186	CbGpPWpGaD
Lomitapide—Vomiting—Vigabatrin—epilepsy syndrome	4.56e-05	0.000412	CcSEcCtD
Lomitapide—Skin disorder—Valproic Acid—epilepsy syndrome	4.55e-05	0.000412	CcSEcCtD
Lomitapide—Urinary tract disorder—Topiramate—epilepsy syndrome	4.55e-05	0.000411	CcSEcCtD
Lomitapide—Hyperhidrosis—Valproic Acid—epilepsy syndrome	4.53e-05	0.00041	CcSEcCtD
Lomitapide—Connective tissue disorder—Topiramate—epilepsy syndrome	4.52e-05	0.000409	CcSEcCtD
Lomitapide—Nausea—Levetiracetam—epilepsy syndrome	4.52e-05	0.000409	CcSEcCtD
Lomitapide—ABCB1—Allograft Rejection—CXCL12—epilepsy syndrome	4.52e-05	0.00184	CbGpPWpGaD
Lomitapide—Dizziness—Felbamate—epilepsy syndrome	4.51e-05	0.000408	CcSEcCtD
Lomitapide—Urethral disorder—Topiramate—epilepsy syndrome	4.51e-05	0.000408	CcSEcCtD
Lomitapide—Headache—Vigabatrin—epilepsy syndrome	4.49e-05	0.000406	CcSEcCtD
Lomitapide—Vomiting—Diazepam—epilepsy syndrome	4.48e-05	0.000406	CcSEcCtD
Lomitapide—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—epilepsy syndrome	4.48e-05	0.00182	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—CD40—epilepsy syndrome	4.47e-05	0.00182	CbGpPWpGaD
Lomitapide—Myalgia—Pregabalin—epilepsy syndrome	4.42e-05	0.0004	CcSEcCtD
Lomitapide—Arthralgia—Pregabalin—epilepsy syndrome	4.42e-05	0.0004	CcSEcCtD
Lomitapide—Chest pain—Pregabalin—epilepsy syndrome	4.42e-05	0.0004	CcSEcCtD
Lomitapide—Ill-defined disorder—Gabapentin—epilepsy syndrome	4.42e-05	0.0004	CcSEcCtD
Lomitapide—Dizziness—Zonisamide—epilepsy syndrome	4.42e-05	0.0004	CcSEcCtD
Lomitapide—Headache—Diazepam—epilepsy syndrome	4.42e-05	0.0004	CcSEcCtD
Lomitapide—Diarrhoea—Clonazepam—epilepsy syndrome	4.41e-05	0.000399	CcSEcCtD
Lomitapide—Anaemia—Gabapentin—epilepsy syndrome	4.4e-05	0.000398	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	4.39e-05	0.000397	CcSEcCtD
Lomitapide—Asthenia—Carbamazepine—epilepsy syndrome	4.38e-05	0.000396	CcSEcCtD
Lomitapide—Diarrhoea—Phenytoin—epilepsy syndrome	4.38e-05	0.000396	CcSEcCtD
Lomitapide—Discomfort—Pregabalin—epilepsy syndrome	4.37e-05	0.000395	CcSEcCtD
Lomitapide—Nausea—Fosphenytoin—epilepsy syndrome	4.37e-05	0.000395	CcSEcCtD
Lomitapide—Diarrhoea—Oxcarbazepine—epilepsy syndrome	4.35e-05	0.000394	CcSEcCtD
Lomitapide—Vomiting—Felbamate—epilepsy syndrome	4.34e-05	0.000393	CcSEcCtD
Lomitapide—Dry mouth—Pregabalin—epilepsy syndrome	4.33e-05	0.000391	CcSEcCtD
Lomitapide—Eye disorder—Topiramate—epilepsy syndrome	4.3e-05	0.000389	CcSEcCtD
Lomitapide—Malaise—Gabapentin—epilepsy syndrome	4.3e-05	0.000389	CcSEcCtD
Lomitapide—Vertigo—Gabapentin—epilepsy syndrome	4.28e-05	0.000387	CcSEcCtD
Lomitapide—Headache—Felbamate—epilepsy syndrome	4.28e-05	0.000387	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	4.27e-05	0.000386	CcSEcCtD
Lomitapide—Cardiac disorder—Topiramate—epilepsy syndrome	4.27e-05	0.000386	CcSEcCtD
Lomitapide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—epilepsy syndrome	4.26e-05	0.00174	CbGpPWpGaD
Lomitapide—Dizziness—Clonazepam—epilepsy syndrome	4.26e-05	0.000385	CcSEcCtD
Lomitapide—Nausea—Vigabatrin—epilepsy syndrome	4.26e-05	0.000385	CcSEcCtD
Lomitapide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—epilepsy syndrome	4.26e-05	0.00173	CbGpPWpGaD
Lomitapide—Vomiting—Zonisamide—epilepsy syndrome	4.25e-05	0.000384	CcSEcCtD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—HMOX1—epilepsy syndrome	4.24e-05	0.00173	CbGpPWpGaD
Lomitapide—Asthenia—Lamotrigine—epilepsy syndrome	4.23e-05	0.000383	CcSEcCtD
Lomitapide—Dizziness—Phenytoin—epilepsy syndrome	4.23e-05	0.000383	CcSEcCtD
Lomitapide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C19—epilepsy syndrome	4.23e-05	0.00172	CbGpPWpGaD
Lomitapide—Infection—Pregabalin—epilepsy syndrome	4.21e-05	0.000381	CcSEcCtD
Lomitapide—Paraesthesia—Valproic Acid—epilepsy syndrome	4.21e-05	0.000381	CcSEcCtD
Lomitapide—Palpitations—Gabapentin—epilepsy syndrome	4.21e-05	0.000381	CcSEcCtD
Lomitapide—Dizziness—Oxcarbazepine—epilepsy syndrome	4.21e-05	0.000381	CcSEcCtD
Lomitapide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—epilepsy syndrome	4.2e-05	0.00171	CbGpPWpGaD
Lomitapide—Nausea—Diazepam—epilepsy syndrome	4.19e-05	0.000379	CcSEcCtD
Lomitapide—Headache—Zonisamide—epilepsy syndrome	4.19e-05	0.000379	CcSEcCtD
Lomitapide—Diarrhoea—Carbamazepine—epilepsy syndrome	4.18e-05	0.000378	CcSEcCtD
Lomitapide—CYP3A4—Oxidation by Cytochrome P450—CYP2C19—epilepsy syndrome	4.17e-05	0.0017	CbGpPWpGaD
Lomitapide—Somnolence—Valproic Acid—epilepsy syndrome	4.17e-05	0.000377	CcSEcCtD
Lomitapide—Nervous system disorder—Pregabalin—epilepsy syndrome	4.16e-05	0.000376	CcSEcCtD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	4.15e-05	0.00169	CbGpPWpGaD
Lomitapide—Mediastinal disorder—Topiramate—epilepsy syndrome	4.15e-05	0.000375	CcSEcCtD
Lomitapide—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—epilepsy syndrome	4.15e-05	0.00169	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—CYP2D6—epilepsy syndrome	4.14e-05	0.00169	CbGpPWpGaD
Lomitapide—Chills—Topiramate—epilepsy syndrome	4.13e-05	0.000374	CcSEcCtD
Lomitapide—Dyspepsia—Valproic Acid—epilepsy syndrome	4.13e-05	0.000373	CcSEcCtD
Lomitapide—Skin disorder—Pregabalin—epilepsy syndrome	4.12e-05	0.000372	CcSEcCtD
Lomitapide—Hyperhidrosis—Pregabalin—epilepsy syndrome	4.1e-05	0.000371	CcSEcCtD
Lomitapide—Vomiting—Clonazepam—epilepsy syndrome	4.09e-05	0.00037	CcSEcCtD
Lomitapide—Decreased appetite—Valproic Acid—epilepsy syndrome	4.08e-05	0.000369	CcSEcCtD
Lomitapide—Vomiting—Phenytoin—epilepsy syndrome	4.07e-05	0.000368	CcSEcCtD
Lomitapide—Myalgia—Gabapentin—epilepsy syndrome	4.06e-05	0.000367	CcSEcCtD
Lomitapide—Chest pain—Gabapentin—epilepsy syndrome	4.06e-05	0.000367	CcSEcCtD
Lomitapide—Arthralgia—Gabapentin—epilepsy syndrome	4.06e-05	0.000367	CcSEcCtD
Lomitapide—Nausea—Felbamate—epilepsy syndrome	4.05e-05	0.000367	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	4.05e-05	0.000366	CcSEcCtD
Lomitapide—Vomiting—Oxcarbazepine—epilepsy syndrome	4.05e-05	0.000366	CcSEcCtD
Lomitapide—Fatigue—Valproic Acid—epilepsy syndrome	4.04e-05	0.000366	CcSEcCtD
Lomitapide—Dizziness—Carbamazepine—epilepsy syndrome	4.04e-05	0.000365	CcSEcCtD
Lomitapide—Diarrhoea—Lamotrigine—epilepsy syndrome	4.04e-05	0.000365	CcSEcCtD
Lomitapide—Headache—Clonazepam—epilepsy syndrome	4.03e-05	0.000365	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	4.03e-05	0.000364	CcSEcCtD
Lomitapide—Constipation—Valproic Acid—epilepsy syndrome	4.01e-05	0.000363	CcSEcCtD
Lomitapide—Headache—Phenytoin—epilepsy syndrome	4.01e-05	0.000363	CcSEcCtD
Lomitapide—Malnutrition—Topiramate—epilepsy syndrome	4.01e-05	0.000363	CcSEcCtD
Lomitapide—Discomfort—Gabapentin—epilepsy syndrome	4.01e-05	0.000362	CcSEcCtD
Lomitapide—Headache—Oxcarbazepine—epilepsy syndrome	3.99e-05	0.000361	CcSEcCtD
Lomitapide—Nausea—Zonisamide—epilepsy syndrome	3.97e-05	0.000359	CcSEcCtD
Lomitapide—Dry mouth—Gabapentin—epilepsy syndrome	3.97e-05	0.000359	CcSEcCtD
Lomitapide—Flatulence—Topiramate—epilepsy syndrome	3.95e-05	0.000357	CcSEcCtD
Lomitapide—MTTP—Metabolism—ADRA2A—epilepsy syndrome	3.94e-05	0.00161	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—BCHE—epilepsy syndrome	3.93e-05	0.0016	CbGpPWpGaD
Lomitapide—Dizziness—Lamotrigine—epilepsy syndrome	3.9e-05	0.000353	CcSEcCtD
Lomitapide—Vomiting—Carbamazepine—epilepsy syndrome	3.88e-05	0.000351	CcSEcCtD
Lomitapide—Back pain—Topiramate—epilepsy syndrome	3.88e-05	0.000351	CcSEcCtD
Lomitapide—Feeling abnormal—Valproic Acid—epilepsy syndrome	3.86e-05	0.00035	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	3.86e-05	0.000349	CcSEcCtD
Lomitapide—Infection—Gabapentin—epilepsy syndrome	3.86e-05	0.000349	CcSEcCtD
Lomitapide—Muscle spasms—Topiramate—epilepsy syndrome	3.85e-05	0.000349	CcSEcCtD
Lomitapide—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	3.83e-05	0.000347	CcSEcCtD
Lomitapide—Nausea—Clonazepam—epilepsy syndrome	3.83e-05	0.000346	CcSEcCtD
Lomitapide—Headache—Carbamazepine—epilepsy syndrome	3.83e-05	0.000346	CcSEcCtD
Lomitapide—Nervous system disorder—Gabapentin—epilepsy syndrome	3.81e-05	0.000345	CcSEcCtD
Lomitapide—Paraesthesia—Pregabalin—epilepsy syndrome	3.81e-05	0.000344	CcSEcCtD
Lomitapide—Nausea—Phenytoin—epilepsy syndrome	3.8e-05	0.000344	CcSEcCtD
Lomitapide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—epilepsy syndrome	3.79e-05	0.00155	CbGpPWpGaD
Lomitapide—Nausea—Oxcarbazepine—epilepsy syndrome	3.78e-05	0.000342	CcSEcCtD
Lomitapide—Skin disorder—Gabapentin—epilepsy syndrome	3.78e-05	0.000342	CcSEcCtD
Lomitapide—Somnolence—Pregabalin—epilepsy syndrome	3.77e-05	0.000341	CcSEcCtD
Lomitapide—Hyperhidrosis—Gabapentin—epilepsy syndrome	3.76e-05	0.00034	CcSEcCtD
Lomitapide—Vomiting—Lamotrigine—epilepsy syndrome	3.75e-05	0.000339	CcSEcCtD
Lomitapide—MTTP—Metabolism—SLC2A1—epilepsy syndrome	3.75e-05	0.00153	CbGpPWpGaD
Lomitapide—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—epilepsy syndrome	3.74e-05	0.00152	CbGpPWpGaD
Lomitapide—Ill-defined disorder—Topiramate—epilepsy syndrome	3.72e-05	0.000336	CcSEcCtD
Lomitapide—Abdominal pain—Valproic Acid—epilepsy syndrome	3.71e-05	0.000335	CcSEcCtD
Lomitapide—Body temperature increased—Valproic Acid—epilepsy syndrome	3.71e-05	0.000335	CcSEcCtD
Lomitapide—MTTP—Metabolism—PLCB1—epilepsy syndrome	3.71e-05	0.00151	CbGpPWpGaD
Lomitapide—Anaemia—Topiramate—epilepsy syndrome	3.7e-05	0.000335	CcSEcCtD
Lomitapide—Headache—Lamotrigine—epilepsy syndrome	3.7e-05	0.000334	CcSEcCtD
Lomitapide—MTTP—Metabolism—TH—epilepsy syndrome	3.69e-05	0.0015	CbGpPWpGaD
Lomitapide—Decreased appetite—Pregabalin—epilepsy syndrome	3.69e-05	0.000333	CcSEcCtD
Lomitapide—ABCB1—Transmembrane transport of small molecules—CLCN2—epilepsy syndrome	3.67e-05	0.0015	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—CLCN6—epilepsy syndrome	3.67e-05	0.0015	CbGpPWpGaD
Lomitapide—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	3.66e-05	0.000331	CcSEcCtD
Lomitapide—Fatigue—Pregabalin—epilepsy syndrome	3.66e-05	0.000331	CcSEcCtD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	3.63e-05	0.00148	CbGpPWpGaD
Lomitapide—Nausea—Carbamazepine—epilepsy syndrome	3.63e-05	0.000328	CcSEcCtD
Lomitapide—Constipation—Pregabalin—epilepsy syndrome	3.63e-05	0.000328	CcSEcCtD
Lomitapide—Malaise—Topiramate—epilepsy syndrome	3.61e-05	0.000327	CcSEcCtD
Lomitapide—Vertigo—Topiramate—epilepsy syndrome	3.6e-05	0.000326	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	3.54e-05	0.00032	CcSEcCtD
Lomitapide—Palpitations—Topiramate—epilepsy syndrome	3.54e-05	0.00032	CcSEcCtD
Lomitapide—Nausea—Lamotrigine—epilepsy syndrome	3.51e-05	0.000317	CcSEcCtD
Lomitapide—Feeling abnormal—Pregabalin—epilepsy syndrome	3.49e-05	0.000316	CcSEcCtD
Lomitapide—Paraesthesia—Gabapentin—epilepsy syndrome	3.49e-05	0.000316	CcSEcCtD
Lomitapide—Gastrointestinal pain—Pregabalin—epilepsy syndrome	3.47e-05	0.000314	CcSEcCtD
Lomitapide—Somnolence—Gabapentin—epilepsy syndrome	3.46e-05	0.000313	CcSEcCtD
Lomitapide—CYP3A4—Tryptophan metabolism—CAT—epilepsy syndrome	3.44e-05	0.0014	CbGpPWpGaD
Lomitapide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C19—epilepsy syndrome	3.43e-05	0.0014	CbGpPWpGaD
Lomitapide—Dyspepsia—Gabapentin—epilepsy syndrome	3.42e-05	0.00031	CcSEcCtD
Lomitapide—Arthralgia—Topiramate—epilepsy syndrome	3.41e-05	0.000309	CcSEcCtD
Lomitapide—Myalgia—Topiramate—epilepsy syndrome	3.41e-05	0.000309	CcSEcCtD
Lomitapide—Chest pain—Topiramate—epilepsy syndrome	3.41e-05	0.000309	CcSEcCtD
Lomitapide—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—epilepsy syndrome	3.41e-05	0.00139	CbGpPWpGaD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	3.39e-05	0.000306	CcSEcCtD
Lomitapide—Decreased appetite—Gabapentin—epilepsy syndrome	3.38e-05	0.000306	CcSEcCtD
Lomitapide—Discomfort—Topiramate—epilepsy syndrome	3.37e-05	0.000305	CcSEcCtD
Lomitapide—Asthenia—Valproic Acid—epilepsy syndrome	3.36e-05	0.000304	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	3.36e-05	0.000304	CcSEcCtD
Lomitapide—Fatigue—Gabapentin—epilepsy syndrome	3.35e-05	0.000303	CcSEcCtD
Lomitapide—Body temperature increased—Pregabalin—epilepsy syndrome	3.35e-05	0.000303	CcSEcCtD
Lomitapide—Abdominal pain—Pregabalin—epilepsy syndrome	3.35e-05	0.000303	CcSEcCtD
Lomitapide—Dry mouth—Topiramate—epilepsy syndrome	3.34e-05	0.000302	CcSEcCtD
Lomitapide—Constipation—Gabapentin—epilepsy syndrome	3.32e-05	0.000301	CcSEcCtD
Lomitapide—ABCB1—Transmembrane transport of small molecules—SLC35A3—epilepsy syndrome	3.27e-05	0.00133	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—SLC12A5—epilepsy syndrome	3.27e-05	0.00133	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—SLC35A2—epilepsy syndrome	3.27e-05	0.00133	CbGpPWpGaD
Lomitapide—Infection—Topiramate—epilepsy syndrome	3.25e-05	0.000294	CcSEcCtD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—JUND—epilepsy syndrome	3.22e-05	0.00131	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—EIF2AK2—epilepsy syndrome	3.22e-05	0.00131	CbGpPWpGaD
Lomitapide—Diarrhoea—Valproic Acid—epilepsy syndrome	3.21e-05	0.00029	CcSEcCtD
Lomitapide—Nervous system disorder—Topiramate—epilepsy syndrome	3.21e-05	0.00029	CcSEcCtD
Lomitapide—Feeling abnormal—Gabapentin—epilepsy syndrome	3.2e-05	0.00029	CcSEcCtD
Lomitapide—Gastrointestinal pain—Gabapentin—epilepsy syndrome	3.18e-05	0.000288	CcSEcCtD
Lomitapide—Skin disorder—Topiramate—epilepsy syndrome	3.18e-05	0.000287	CcSEcCtD
Lomitapide—Hyperhidrosis—Topiramate—epilepsy syndrome	3.16e-05	0.000286	CcSEcCtD
Lomitapide—Dizziness—Valproic Acid—epilepsy syndrome	3.1e-05	0.000281	CcSEcCtD
Lomitapide—MTTP—Metabolism—HMOX1—epilepsy syndrome	3.08e-05	0.00126	CbGpPWpGaD
Lomitapide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—epilepsy syndrome	3.07e-05	0.00125	CbGpPWpGaD
Lomitapide—Abdominal pain—Gabapentin—epilepsy syndrome	3.07e-05	0.000278	CcSEcCtD
Lomitapide—Body temperature increased—Gabapentin—epilepsy syndrome	3.07e-05	0.000278	CcSEcCtD
Lomitapide—Asthenia—Pregabalin—epilepsy syndrome	3.04e-05	0.000275	CcSEcCtD
Lomitapide—MTTP—Metabolism—CAT—epilepsy syndrome	3.04e-05	0.00124	CbGpPWpGaD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—NOS2—epilepsy syndrome	3.03e-05	0.00124	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—SLC4A10—epilepsy syndrome	2.99e-05	0.00122	CbGpPWpGaD
Lomitapide—Vomiting—Valproic Acid—epilepsy syndrome	2.98e-05	0.00027	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	2.98e-05	0.00027	CcSEcCtD
Lomitapide—MTTP—Metabolism—ABCB1—epilepsy syndrome	2.96e-05	0.00121	CbGpPWpGaD
Lomitapide—Headache—Valproic Acid—epilepsy syndrome	2.94e-05	0.000266	CcSEcCtD
Lomitapide—Paraesthesia—Topiramate—epilepsy syndrome	2.94e-05	0.000266	CcSEcCtD
Lomitapide—Somnolence—Topiramate—epilepsy syndrome	2.91e-05	0.000263	CcSEcCtD
Lomitapide—Diarrhoea—Pregabalin—epilepsy syndrome	2.9e-05	0.000262	CcSEcCtD
Lomitapide—Dyspepsia—Topiramate—epilepsy syndrome	2.88e-05	0.00026	CcSEcCtD
Lomitapide—Decreased appetite—Topiramate—epilepsy syndrome	2.84e-05	0.000257	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Topiramate—epilepsy syndrome	2.82e-05	0.000255	CcSEcCtD
Lomitapide—Fatigue—Topiramate—epilepsy syndrome	2.82e-05	0.000255	CcSEcCtD
Lomitapide—Dizziness—Pregabalin—epilepsy syndrome	2.8e-05	0.000254	CcSEcCtD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—FOS—epilepsy syndrome	2.8e-05	0.00114	CbGpPWpGaD
Lomitapide—Constipation—Topiramate—epilepsy syndrome	2.8e-05	0.000253	CcSEcCtD
Lomitapide—Asthenia—Gabapentin—epilepsy syndrome	2.79e-05	0.000252	CcSEcCtD
Lomitapide—Nausea—Valproic Acid—epilepsy syndrome	2.79e-05	0.000252	CcSEcCtD
Lomitapide—MTTP—Metabolism—GPX1—epilepsy syndrome	2.75e-05	0.00112	CbGpPWpGaD
Lomitapide—Vomiting—Pregabalin—epilepsy syndrome	2.7e-05	0.000244	CcSEcCtD
Lomitapide—Feeling abnormal—Topiramate—epilepsy syndrome	2.7e-05	0.000244	CcSEcCtD
Lomitapide—Gastrointestinal pain—Topiramate—epilepsy syndrome	2.67e-05	0.000242	CcSEcCtD
Lomitapide—Diarrhoea—Gabapentin—epilepsy syndrome	2.66e-05	0.000241	CcSEcCtD
Lomitapide—Headache—Pregabalin—epilepsy syndrome	2.66e-05	0.00024	CcSEcCtD
Lomitapide—ABCB1—Transmembrane transport of small molecules—COX3—epilepsy syndrome	2.61e-05	0.00107	CbGpPWpGaD
Lomitapide—Abdominal pain—Topiramate—epilepsy syndrome	2.59e-05	0.000234	CcSEcCtD
Lomitapide—Body temperature increased—Topiramate—epilepsy syndrome	2.59e-05	0.000234	CcSEcCtD
Lomitapide—Dizziness—Gabapentin—epilepsy syndrome	2.57e-05	0.000233	CcSEcCtD
Lomitapide—Nausea—Pregabalin—epilepsy syndrome	2.52e-05	0.000228	CcSEcCtD
Lomitapide—ABCB1—Transmembrane transport of small molecules—SLC8A2—epilepsy syndrome	2.48e-05	0.00101	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—SLCO1A2—epilepsy syndrome	2.48e-05	0.00101	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—SLC9A6—epilepsy syndrome	2.48e-05	0.00101	CbGpPWpGaD
Lomitapide—Vomiting—Gabapentin—epilepsy syndrome	2.47e-05	0.000224	CcSEcCtD
Lomitapide—Headache—Gabapentin—epilepsy syndrome	2.44e-05	0.00022	CcSEcCtD
Lomitapide—MTTP—Metabolism—AGT—epilepsy syndrome	2.41e-05	0.000983	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—CASP8—epilepsy syndrome	2.37e-05	0.000965	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—SLC8A3—epilepsy syndrome	2.36e-05	0.000964	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—GABRG2—epilepsy syndrome	2.36e-05	0.000964	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—APOE—epilepsy syndrome	2.36e-05	0.000963	CbGpPWpGaD
Lomitapide—Asthenia—Topiramate—epilepsy syndrome	2.35e-05	0.000212	CcSEcCtD
Lomitapide—Nausea—Gabapentin—epilepsy syndrome	2.31e-05	0.000209	CcSEcCtD
Lomitapide—Diarrhoea—Topiramate—epilepsy syndrome	2.24e-05	0.000202	CcSEcCtD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—JUNB—epilepsy syndrome	2.19e-05	0.000892	CbGpPWpGaD
Lomitapide—Dizziness—Topiramate—epilepsy syndrome	2.16e-05	0.000196	CcSEcCtD
Lomitapide—Vomiting—Topiramate—epilepsy syndrome	2.08e-05	0.000188	CcSEcCtD
Lomitapide—Headache—Topiramate—epilepsy syndrome	2.05e-05	0.000185	CcSEcCtD
Lomitapide—MTTP—Metabolism—POMC—epilepsy syndrome	2.03e-05	0.000827	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CA13—epilepsy syndrome	2.02e-05	0.000824	CbGpPWpGaD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—JUN—epilepsy syndrome	2.01e-05	0.000819	CbGpPWpGaD
Lomitapide—Nausea—Topiramate—epilepsy syndrome	1.94e-05	0.000176	CcSEcCtD
Lomitapide—ABCB1—Transmembrane transport of small molecules—APOD—epilepsy syndrome	1.93e-05	0.000786	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—SLC12A2—epilepsy syndrome	1.88e-05	0.000766	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—SLC1A1—epilepsy syndrome	1.88e-05	0.000766	CbGpPWpGaD
Lomitapide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	1.86e-05	0.000757	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—ALB—epilepsy syndrome	1.85e-05	0.000754	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—CYP2C19—epilepsy syndrome	1.82e-05	0.000742	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—CYP11A1—epilepsy syndrome	1.81e-05	0.000737	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—IL1B—epilepsy syndrome	1.8e-05	0.000732	CbGpPWpGaD
Lomitapide—CYP3A4—Metapathway biotransformation—CYP2C19—epilepsy syndrome	1.8e-05	0.000732	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—GABRA5—epilepsy syndrome	1.79e-05	0.00073	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—CASP3—epilepsy syndrome	1.79e-05	0.00073	CbGpPWpGaD
Lomitapide—CYP3A4—Metapathway biotransformation—CYP11A1—epilepsy syndrome	1.78e-05	0.000727	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—epilepsy syndrome	1.77e-05	0.000721	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—epilepsy syndrome	1.76e-05	0.000718	CbGpPWpGaD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—VEGFA—epilepsy syndrome	1.76e-05	0.000715	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	1.72e-05	0.0007	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—GABRA1—epilepsy syndrome	1.72e-05	0.0007	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	1.72e-05	0.0007	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	1.72e-05	0.0007	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—CYP2D6—epilepsy syndrome	1.63e-05	0.000665	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—PTGS2—epilepsy syndrome	1.62e-05	0.00066	CbGpPWpGaD
Lomitapide—CYP3A4—Metapathway biotransformation—CYP2D6—epilepsy syndrome	1.61e-05	0.000656	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	1.6e-05	0.000651	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—ADK—epilepsy syndrome	1.53e-05	0.000624	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—FAR1—epilepsy syndrome	1.53e-05	0.000624	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CERS1—epilepsy syndrome	1.53e-05	0.000624	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—GLUD1—epilepsy syndrome	1.53e-05	0.000624	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PDXK—epilepsy syndrome	1.53e-05	0.000624	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—L2HGDH—epilepsy syndrome	1.53e-05	0.000624	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	1.52e-05	0.000621	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—VEGFA—epilepsy syndrome	1.52e-05	0.00062	CbGpPWpGaD
Lomitapide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	1.51e-05	0.000614	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	1.5e-05	0.000612	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	1.46e-05	0.000595	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	1.41e-05	0.000573	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—GAMT—epilepsy syndrome	1.4e-05	0.000571	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—EPM2A—epilepsy syndrome	1.4e-05	0.000571	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—NHLRC1—epilepsy syndrome	1.4e-05	0.000571	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PNPO—epilepsy syndrome	1.4e-05	0.000571	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	1.36e-05	0.000553	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	1.36e-05	0.000553	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—epilepsy syndrome	1.34e-05	0.000545	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—TNF—epilepsy syndrome	1.3e-05	0.000531	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CA4—epilepsy syndrome	1.3e-05	0.000531	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—QDPR—epilepsy syndrome	1.3e-05	0.000531	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	1.3e-05	0.000531	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CA13—epilepsy syndrome	1.25e-05	0.000507	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—COX3—epilepsy syndrome	1.22e-05	0.000499	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	1.21e-05	0.000493	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—epilepsy syndrome	1.17e-05	0.000476	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—SLCO1A2—epilepsy syndrome	1.16e-05	0.000473	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PFKL—epilepsy syndrome	1.16e-05	0.000473	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—KCNB1—epilepsy syndrome	1.16e-05	0.000473	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CACNA2D2—epilepsy syndrome	1.16e-05	0.000473	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—SLC6A8—epilepsy syndrome	1.16e-05	0.000473	CbGpPWpGaD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—AKT1—epilepsy syndrome	1.12e-05	0.000456	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	1.11e-05	0.000451	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	1.08e-05	0.00044	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—NEU1—epilepsy syndrome	1.06e-05	0.000433	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—ATIC—epilepsy syndrome	1.06e-05	0.000433	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—UPB1—epilepsy syndrome	1.06e-05	0.000433	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—epilepsy syndrome	1.06e-05	0.00043	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—HSD17B4—epilepsy syndrome	1.02e-05	0.000417	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—epilepsy syndrome	1e-05	0.000409	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—GBE1—epilepsy syndrome	9.87e-06	0.000402	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PPP1R3C—epilepsy syndrome	9.87e-06	0.000402	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—epilepsy syndrome	9.52e-06	0.000388	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	9.44e-06	0.000385	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—FAR1—epilepsy syndrome	9.44e-06	0.000385	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	9.44e-06	0.000385	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—ADK—epilepsy syndrome	9.44e-06	0.000385	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CERS1—epilepsy syndrome	9.44e-06	0.000385	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PDXK—epilepsy syndrome	9.44e-06	0.000385	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—ASAH1—epilepsy syndrome	9.28e-06	0.000378	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	9.17e-06	0.000374	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—STXBP1—epilepsy syndrome	9.03e-06	0.000368	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—epilepsy syndrome	8.84e-06	0.00036	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—NT5E—epilepsy syndrome	8.8e-06	0.000359	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—ALAD—epilepsy syndrome	8.8e-06	0.000359	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	8.75e-06	0.000357	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	8.63e-06	0.000352	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—GAMT—epilepsy syndrome	8.63e-06	0.000352	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	8.63e-06	0.000352	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PNPO—epilepsy syndrome	8.63e-06	0.000352	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	8.59e-06	0.00035	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CACNA1A—epilepsy syndrome	8.39e-06	0.000342	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—ALDH7A1—epilepsy syndrome	8.39e-06	0.000342	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—ST3GAL3—epilepsy syndrome	8.21e-06	0.000335	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—AKT1—epilepsy syndrome	8.14e-06	0.000332	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—ADSL—epilepsy syndrome	8.05e-06	0.000328	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—QDPR—epilepsy syndrome	8.02e-06	0.000327	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CA4—epilepsy syndrome	8.02e-06	0.000327	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	8e-06	0.000326	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—GLUL—epilepsy syndrome	7.89e-06	0.000322	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CACNA1D—epilepsy syndrome	7.75e-06	0.000316	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	7.7e-06	0.000314	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—COX3—epilepsy syndrome	7.54e-06	0.000307	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	7.5e-06	0.000306	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—TXNRD1—epilepsy syndrome	7.24e-06	0.000295	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	7.2e-06	0.000293	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	7.15e-06	0.000291	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PFKL—epilepsy syndrome	7.15e-06	0.000291	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	7.15e-06	0.000291	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	7.15e-06	0.000291	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	7.15e-06	0.000291	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	7.13e-06	0.000291	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—AQP1—epilepsy syndrome	7.03e-06	0.000287	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—NEU1—epilepsy syndrome	6.54e-06	0.000267	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—UPB1—epilepsy syndrome	6.54e-06	0.000267	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—ATIC—epilepsy syndrome	6.54e-06	0.000267	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	6.43e-06	0.000262	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—KCNJ11—epilepsy syndrome	6.36e-06	0.000259	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CHRM3—epilepsy syndrome	6.36e-06	0.000259	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	6.3e-06	0.000257	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	6.08e-06	0.000248	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—GBE1—epilepsy syndrome	6.08e-06	0.000248	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	5.72e-06	0.000233	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	5.56e-06	0.000227	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—NT5E—epilepsy syndrome	5.42e-06	0.000221	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—ALAD—epilepsy syndrome	5.42e-06	0.000221	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—ABCG2—epilepsy syndrome	5.18e-06	0.000211	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	5.17e-06	0.000211	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	5.17e-06	0.000211	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	5.06e-06	0.000206	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	5.05e-06	0.000206	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	5.02e-06	0.000205	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—ADSL—epilepsy syndrome	4.96e-06	0.000202	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—GLUL—epilepsy syndrome	4.86e-06	0.000198	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	4.79e-06	0.000195	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	4.77e-06	0.000194	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	4.53e-06	0.000185	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	4.46e-06	0.000182	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—AQP1—epilepsy syndrome	4.33e-06	0.000177	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	4.32e-06	0.000176	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	4.31e-06	0.000176	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—BCHE—epilepsy syndrome	4.3e-06	0.000175	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	4.1e-06	0.000167	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PLCB1—epilepsy syndrome	4.05e-06	0.000165	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—TH—epilepsy syndrome	4.04e-06	0.000165	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	3.92e-06	0.00016	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	3.92e-06	0.00016	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—HMOX1—epilepsy syndrome	3.37e-06	0.000137	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CAT—epilepsy syndrome	3.33e-06	0.000136	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	3.19e-06	0.00013	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	3.11e-06	0.000127	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	3.09e-06	0.000126	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—GPX1—epilepsy syndrome	3.01e-06	0.000123	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	2.79e-06	0.000114	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	2.66e-06	0.000108	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—BCHE—epilepsy syndrome	2.65e-06	0.000108	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—AGT—epilepsy syndrome	2.64e-06	0.000108	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—APOE—epilepsy syndrome	2.58e-06	0.000105	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	2.53e-06	0.000103	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	2.5e-06	0.000102	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—TH—epilepsy syndrome	2.49e-06	0.000101	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—POMC—epilepsy syndrome	2.22e-06	9.05e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	2.08e-06	8.47e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CAT—epilepsy syndrome	2.05e-06	8.35e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—ALB—epilepsy syndrome	2.02e-06	8.25e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	1.99e-06	8.13e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—GPX1—epilepsy syndrome	1.85e-06	7.55e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PTGS2—epilepsy syndrome	1.77e-06	7.22e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—AGT—epilepsy syndrome	1.63e-06	6.62e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—APOE—epilepsy syndrome	1.59e-06	6.49e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—POMC—epilepsy syndrome	1.37e-06	5.58e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—ALB—epilepsy syndrome	1.25e-06	5.08e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	1.09e-06	4.45e-05	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—AKT1—epilepsy syndrome	8.9e-07	3.63e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—AKT1—epilepsy syndrome	5.48e-07	2.23e-05	CbGpPWpGaD
